MoneyWorks4Me

Marksans Pharma - Quaterly Results

11 Aug 2023 Evaluate
The company witnessed a 14.38% growth in the revenue at Rs. 1820.41 millions for the quarter ended June 2023 as compared to Rs. 1591.52 millions during the year-ago period.Net Profit for the quarter ended June 2023 zoomed to 130.09% from Rs. 192.06 millions to Rs. 441.91  millions.OP of the company witnessed a marginal growth to 593.81 millions from 310.39 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 1820.41 1591.52 14.38 1820.41 1591.52 14.38 6552.04 6582.89 -0.47
Other Income 326.23 194.32 67.88 326.23 194.32 67.88 604.82 422.51 43.15
PBIDT 593.81 310.39 91.31 593.81 310.39 91.31 1523.85 1559.66 -2.30
Interest 2.62 8.17 -67.93 2.62 8.17 -67.93 36.13 37.95 -4.80
PBDT 591.19 302.22 95.62 591.19 302.22 95.62 1487.72 1521.71 -2.23
Depreciation 47.24 45.18 4.56 47.24 45.18 4.56 167.37 176.63 -5.24
PBT 543.95 257.04 111.62 543.95 257.04 111.62 1320.35 1345.08 -1.84
TAX 102.04 64.98 57.03 102.04 64.98 57.03 291.69 305.20 -4.43
Deferred Tax 26.94 -0.94 -2965.96 26.94 -0.94 -2965.96 -1.71 5.04 -133.93
PAT 441.91 192.06 130.09 441.91 192.06 130.09 1028.66 1039.88 -1.08
Equity 453.16 409.31 10.71 453.16 409.31 10.71 453.16 409.31 10.71
PBIDTM(%) 32.62 19.50 67.26 32.62 19.50 67.26 23.26 23.69 -1.84
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..